Trans aTTom A retrospective, prospective translational study to identify and validate biomarkers of late recurraence & adjuvant endocrine therapy benefit in women randomise in the aTTom study to 5 additional years of tamoxifen

  • Rea, Daniel (Principal Investigator)
  • Gaunt, Claire (Co-Investigator)

Project Details

Short titleTrans aTTom A retrospective, prospective translational study to identify and validate biomarkers of late recurraence & adjuvant endocrine therapy benefit in women randomise in the aTTom study to 5 additional years of tamoxifen
StatusFinished
Effective start/end date1/12/15 → 30/06/21

Funding

  • BIOTHERANOSTICS INC